Article info

Download PDFPDF
Dissecting prostate carcinogenesis through ETS gene rearrangement studies: implications for anticancer drug development
  1. Dr Johann S de Bono, Cancer Research UK Centre for Cancer Therapeutics, The Institute for Cancer Research, The Royal Marsden NHS Foundation Trust, Downs Road Sutton, Surrey SM2 5PT, UK; jdebono{at}icr.ac.uk
View Full Text

Citation

Attard G, Ang JE, Olmos D, et al
Dissecting prostate carcinogenesis through ETS gene rearrangement studies: implications for anticancer drug development

Publication history

  • Accepted April 13, 2008
  • First published May 21, 2008.
Online issue publication 
April 18, 2016

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.